Overview
IART market data
Price History
IART price chart · 1M
- O
- 16.32
- H
- 16.78
- L
- 16.31
- C
- 16.70
- Vol
- 23,440.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $16.32
- Previous Close
- $16.42
- Day High
- $16.78
- Day Low
- $16.31
- 52 Week High
- $20.46
- 52 Week Low
- $12.97
- 7 Day Return
- -1.15%
- 30 Day Return
- -5.54%
- 90 Day Return
- -1.53%
- 1 Year Return
- +19.54%
- Daily Notional Volume
- $391.4K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$6.74 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -0.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.70 – $20.49 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.3B · P/B 0.93 · P/S 0.79.
Company News
10 captured
Integra Lifesciences Q2 Adj. EPS $0.56 Beats $0.48 Estimate, Sales $418.761M Beat $418.647M EstimateBenzinga ·
UBS Initiates Coverage On Integra Lifesciences with Neutral Rating, Announces Price Target of $19Benzinga ·